Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€500.80

€500.80

0.540%
2.7
0.540%
€557.75

€557.75

 
28.03.24 / Tradegate WKN: 888210 / Symbol: IDXX / Name: IDEXX Labs / Stock / Healthcare Equipment & Supplies / Large Cap /
Latest predictions
€586.03
06.02.24
-4.97%
buy
€609.54
06.02.24
-4.79%
buy
€598.91
17.01.24
5.72%
buy
06.01.24
2.00%
buy
09.12.23
0.87%
buy
€557.75
07.12.23
2.96%
buy
Best running prediction
€488.51
06.11.23
27.49%
buy
Your prediction

Idexx Laboratories Inc. Stock

The Idexx Laboratories Inc. stock is trending slightly upwards today, with an increase of €2.70 (0.540%) compared to yesterday's price.
With 10 Buy predictions and not the single Sell prediction the community is currently very high on Idexx Laboratories Inc..
With a target price of 557 € there is a slightly positive potential of 11.22% for Idexx Laboratories Inc. compared to the current price of 500.8 €.
Our community identified positive and negative aspects for Idexx Laboratories Inc. stock for the coming years. 1 users see the criterium "EBIT growth" as a plus for the Idexx Laboratories Inc. stock. On the other hand our users think that "Expected dividend yield" could be a problem in the future.

IDEXX Laboratories, Inc. (Symbol: IDXX) is a leading global developer, manufacturer, and distributor of veterinary diagnostic and information technology products and services, primarily catering to companion animal healthcare, livestock and poultry, water testing, and dairy. The company operates through various segments including Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry and Dairy, and Other Veterinary Businesses. Founded in 1983 and headquartered in Westbrook, Maine, IDEXX Labs continues to innovate and grow, driven by a strong commitment to scientific innovation, customer service, and overall animal health and well-being. With a wide range of diagnostic products, software solutions, and connected services, IDXX plays a significant role in the veterinary care industry and serves customers across more than 175 countries.

Pros and Cons of Idexx Laboratories Inc. in the next few years

Pros
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Cons
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Idexx Laboratories Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Idexx Laboratories Inc. 0.540% 2.017% -5.080% 11.264% -0.595% 23.077% 155.562%
Baxter International -0.510% 2.326% 3.259% 7.784% 12.981% -45.642% -44.210%
Dentsply Sirona Inc. -1.290% -0.195% 0.065% -11.622% -4.413% -40.801% -30.091%
Dexcom Inc. 0.170% 4.552% 22.054% 22.589% 14.880% 71.894% 386.184%

Comments

Prediction Buy
Perf. (%) -4.97%
Target price 586.026
Change
Ends at 06.02.25

IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at JPMorgan Chase & Co. from $600.00 to $630.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -4.79%
Target price 609.543
Change
Ends at 06.02.25

IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at Barclays PLC from $605.00 to $655.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 5.72%
Target price 598.910
Change
Ends at 17.01.25

IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $500.00 to $650.00. They now have a "buy" rating on the stock.
Ratings data for IDXX provided by MarketBeat
Show more